Africa: It's Time to Take Decisive Action on Antimicrobial Resistance
[allAfrica] The age of antimicrobial discovery has been overshadowed by the emerging threat of resistance, For too long clinicians like myself have witnessed the impact of antimicrobial resistance -- more commonly referred to as AMR. As a result of this growing health threat, a wide range of infections -- such as pneumonia, tuberculosis, bloodstream infections and gonorrhoea -- have become harder, and sometimes impossible, to treat as more and more antibiotics fail to cure patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2022 Category: African Health Source Type: news

Africa: Antibacterial Resistance Overtakes HIV, Malaria to Become Leading Cause of Deaths
[Capital FM] Nairobi -- New estimates reveal that at least 1.27 million deaths per year are directly attributable to antimicrobial resistance (AMR). (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - January 21, 2022 Category: Infectious Diseases Source Type: news

Antimicrobial Resistance Linked to 1.2 Million Global Deaths Antimicrobial Resistance Linked to 1.2 Million Global Deaths
Researchers take the largest look to date on the impact of bacterial antimicrobial resistance, including most affected agents and regions of the world.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 20, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
More than 1.2 million people - and potentially millions more - died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR). The analysis of 204 countries and territories, published in The Lancet, reveals that AMR is now a leading cause of death worldwide, higher than HIV/AIDS or malaria. (Source: World Pharma News)
Source: World Pharma News - January 20, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Africa: True Scale of Antibiotic Resistance Worldwide Revealed
[Institute for Health Metrics and Evaluation] Based on estimates across 204 countries and territories, the 'Global burden of bacterial antimicrobial resistance in 204 countries and territories in 2019' paper provides the most comprehensive estimate of the global impact of antibiotic resistance to date and reveals that AMR has now become a leading cause of death globally. Published in The Lancet following rigorous external peer review by independent experts, the paper highlights specific areas of concern and equips governments and health co (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 20, 2022 Category: African Health Source Type: news

Antimicrobial resistance kills over 1m people a year, says study
Research underscores the dangers of bacteria developing resistance to antibiotics (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 20, 2022 Category: Pharmaceuticals Source Type: news

Antimicrobial resistance now a leading cause of death worldwide, study finds
Lancet analysis highlights need for urgent action to address antibiotic-resistant bacterial infectionsAntimicrobial resistance poses a significant threat to humanity, health leaders have warned, as a study reveals it has become a leading cause of death worldwide and is killing about 3,500 people every day.More than 1.2 million – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR).The stark analysis covering more than 200 countries and territories w...
Source: Guardian Unlimited Science - January 20, 2022 Category: Science Authors: Andrew Gregory Health editor Tags: Antibiotics Medical research Science World news Society Health Source Type: news

Real-time reviews of research findings will help policymakers address global crises such as COVID-19
Real-time reviews of research findings could help policymakers address global crises such as COVID-19, saysthis   articlepublished   inNature. Living evidence was first developed by Cochrane and an important recommendation for future health emergencies that came out of the recent Cochrane Convenes meetings. According to scientists writing in the peer-reviewed journal  Nature, policy missteps will continue to overshadow the global response to COVID-19 because policymakers are overwhelmed with rapidly shifting research evidence. Faced with new challenges such as the Omicron variant, decisio...
Source: Cochrane News and Events - December 15, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Nigeria: NAFDAC Cautions Against Abuse of Antibiotics
[This Day] The National Agency for Food and Drug Administration and Control, NAFDAC has expressed concerns over the increasing rate of irrational use of antibiotics which it said had further accelerated the process of antimicrobial resistance leading to avoidable deaths. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 29, 2021 Category: African Health Source Type: news

Africa: Antimicrobial Effectiveness Leaning to 'Tipping Point' Resistance - FAO
[UN News] We may soon reach "a tipping point" when antimicrobial resistance (AMR) becomes the leading cause of death - surpassing heart disease and other so-called lifestyle illnesses, the Food and Agricultural Organization (FAO) said on Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 25, 2021 Category: African Health Source Type: news

Antimicrobial  effectiveness leaning towards ‘tipping point’ resistance – FAO 
We may soon reach “a tipping point” when antimicrobial resistance (AMR) becomes the leading cause of death – surpassing heart disease and other so-called lifestyle illnesses, the Food and Agricultural Organization (FAO) said on Wednesday.   (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - November 24, 2021 Category: International Medicine & Public Health Source Type: news

Antibiotic accountability: how countries and companies perform
FT dashboard tracks responses to the growing threat of antimicrobial resistance (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 24, 2021 Category: Pharmaceuticals Source Type: news

Protecting Environmental Water from Antimicrobial Resistance
By Lina Taing and Rachel KaiserHAMILTON, Canada, Nov 23 2021 (IPS) The overuse and misuse of antimicrobial medicines and chemicals has become the main driver of antimicrobial resistance (AMR) and drug-resistant infections that threaten human health and the global economy. Given that development, the UN designated November 18-24 as World Antimicrobial Awareness Week, to remind us all to handle antimicrobials with greater care. Antimicrobials – which range from antibiotic and antiviral medicines to disinfectant and antiseptic chemicals – help prevent or treat human, animal and plant infections and have contribu...
Source: IPS Inter Press Service - Health - November 23, 2021 Category: International Medicine & Public Health Authors: Lina Taing and Rachel Kaiser Tags: Climate Change Environment Global Headlines Health Population Poverty & SDGs TerraViva United Nations Water & Sanitation Source Type: news

Pressure grows for funding to tackle ‘silent pandemic’ of antimicrobial resistance
Political will is needed to address absence of sufficient financial incentives for new drugs (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 19, 2021 Category: Pharmaceuticals Source Type: news

Consumer Health: Are you using antibiotics safely?
The World Health Organization has listed antimicrobial resistance among the top 10 global public health threats. World Antimicrobial Awareness Week, which will be observed Nov. 18 –24, is promoted to increase awareness of the global problem of antimicrobial resistance, and to encourage best practices to avoid the further emergence and spread of drug-resistant infections. Antibiotics are medications used to treat bacterial infections, prevent the spread of disease and reduce serious complications of disease. But some medications… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 19, 2021 Category: Databases & Libraries Source Type: news

Preventing the next public health emergency: New evidence demonstrates need to address antimicrobial resistance
COVID-19 is not the first pandemic caused by a novel strain of a virus affecting the upper respiratory tract.Over the past 100 years, pandemics have been caused by novel forms of influenza and other coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS) and Middle East Severe respiratory syndrome (MERS). Common complications of each of these infections include pneumonia which can lead to secondary bacterial infections requiring treatment with antibiotics. (Source: The Catalyst)
Source: The Catalyst - November 18, 2021 Category: Pharmaceuticals Authors: Jocelyn Ulrich Tags: Research and Development Antimicrobial Resistance Source Type: news

Africa: Stronger Governance Needed to Fight Superbugs in Africa
[WHO-AFRO] Accra -- The leaders of six regional organizations in Africa are calling for stronger governance to fight antimicrobial resistance, or AMR, on the eve of World Antimicrobial Awareness Week (18-24 November). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 18, 2021 Category: African Health Source Type: news

Antimicrobial Resistance Calls for Brainpower of a Space Agency and Campaigning Zeal of an NGO
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 17, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

Gonococcal resistance to antimicrobials surveillance programme report, UK Health Security Agency (updated 17th November 2021)
Data on trends in antimicrobial resistance and decreased susceptibility in gonococcal infection in England and Wales are provided by GRASP. 17 November 2021Added GRASP report: data to June 2021 and slide set. 18 November 2020Added'GRASP report: data to June 2020'and link to the slide set. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 17, 2021 Category: Consumer Health News Source Type: news

Africa: What's Needed to Fight Antimicrobial Resistance? Brainpower and Campaigning Zeal
[The Conversation Africa] The cost of infectious diseases is somewhere between staggering and incalculable. Around $8 trillion and 156 million life years were lost in 2016 alone. Throughout human history, pestilences have wiped out more lives than famine and violence. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 16, 2021 Category: African Health Source Type: news

Antibiotics? Handle with Care
The main drivers of antimicrobial resistance include the misuse and overuse of antimicrobials; lack of access to clean water, sanitation and hygiene for both humans and animals; poor infection and disease prevention and control in health-care facilities and farms; poor access to quality, affordable medicines, vaccines and diagnostics; lack of awareness and knowledge; and lack of enforcement of legislation. Credit: Bigstock.By Baher KamalMADRID, Nov 11 2021 (IPS) The following information is based on investigations and studies carried out by the World Health Organisation (WHO) and the Food and Agriculture Organisation (FAO)...
Source: IPS Inter Press Service - Health - November 11, 2021 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Global Headlines Health Antibiotic Resistance Source Type: news

Combating Antimicrobial Resistance Globally Requires Maintaining Safety of Available Antibiotics and a Robust Pipeline - Animal and Environmental Health Strategies Also Needed
[CDATA[Safe, effective antimicrobial medicines are essential to modern medical procedures and pandemic preparedness. A new National Academies report recommends a range of policy, regulatory, and financial actions to tackle antimicrobial resistance, spanning human, animal, and environmental health.]] (Source: News from the National Academies)
Source: News from the National Academies - October 20, 2021 Category: Science Source Type: news

How a medieval 'leechbook' could be the latest cutting-edge treatment to beat superbugs
The WHO lists antimicrobial resistance as a top ten global health threat, saying that by 2050 it will kill more people than cancer. Could novel vaccines provide new ways to defeat superbugs? (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2021 Category: Consumer Health News Source Type: news

New Welsh animal project launched to combat antimicrobial resistance
A Welsh project designed to help combat antimicrobial resistance in animals and the environment in Wales has been launched. (Source: University of Bristol news)
Source: University of Bristol news - October 6, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Veterinary School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute, Institutes, Cabot, Faculty of Source Type: news

Governments fall behind in race to stem antimicrobial resistance
Without decisive action, there could be 10m deaths a year due to AMR by 2050 — and a cumulative cost to the global economy of $100tn (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 27, 2021 Category: Pharmaceuticals Source Type: news

Defining nosocomial transmission of Escherichia coli and antimicrobial resistance genes: a genomic surveillance study
The authors provide evidence of bacterial transmission and endogenous infection during routine care by integrating genomic and epidemiological data and by determining a genetic cutoff informed by within-host diversity in the studied population. The findings challenge single colony-based investigations, and the widely accepted notion of plasmid spread. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 10, 2021 Category: Consumer Health News Source Type: news

Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future
In the absence of potent antimicrobial agents, it is estimated that bacterial infections could cause millions of deaths. The emergence of COVID-19, its complex pathophysiology and the high propensity of patients to coinfections has resulted in therapeutic regimes that use a cocktail of antibiotics for disease management. Suboptimal antimicrobial stewardship in this era and the slow pace of drug discovery could result in large-scale drug resistance, narrowing future antimicrobial therapeutics. Thus, judicious use of current antimicrobials is imperative to keep up with existing and emerging infectious pathogens. Here, we pro...
Source: Current Awareness Service for Health (CASH) - September 10, 2021 Category: Consumer Health News Source Type: news

Ministerial health declaration
G20 Health Ministers have agreed to collaborate on bolstering health security, increasing vaccine confidence and tackling antimicrobial resistance. (Source: NHS Networks)
Source: NHS Networks - September 7, 2021 Category: UK Health Source Type: news

Rare disease company EnBiotix merges with Swiss firm
EnBiotix Inc., a Boston-based biotech focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. Under the terms of the agreement, Polyphor will acquire all of EnBiotix's outstanding capital stock; EnBiotix will in turn acquire the rights to inhaled murepavadin, a potent antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in cystic fibrosis patients, for $10 million . The merger is expected to close in the fourth quarter… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 1, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Rare disease company EnBiotix merges with Swiss firm
EnBiotix Inc., a Boston-based biotech focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. Under the terms of the agreement, Polyphor will acquire all of EnBiotix's outstanding capital stock; EnBiotix will in turn acquire the rights to inhaled murepavadin, a potent antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in cystic fibrosis patients, for $10 million . The merger is expected to close in the fourth quarter… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 1, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Survey finds antimicrobial resistance important to public, with a high WTP in the UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2021 Category: Drugs & Pharmacology Source Type: news

RPS Pharma Scene Podcast out today with Dame Sally Davies
“Please pharmacists round the world help us,” asks Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance (AMR), and the first special guest on the new RPS Pharma Scene Podcas (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 27, 2021 Category: Drugs & Pharmacology Source Type: news

Resources developed to help reduce the impact of antibiotic resistance
HEE today launches two new videos to help support health and care staff in a variety of settings to understand and prevent the threats posed by antimicrobial resistance. The videos will help health and care staff to: understand the connection between antibiotic use and antibiotic resistance identify their role in optimising antibiotic use and stewardship ensure compliance with national guidance when recommending, prescribing, dispensing and administering antibiotics improve their self-care/safe ty-netting advice to patients on the appropriate use of antibiotics” (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 4, 2021 Category: Consumer Health News Source Type: news

Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey
Survey of 74 TB, gonorrhoea and respiratory tract infection guidelines found relatively few considered resistance at local level, and many did not consider contextual factors necessary for appropriate antimicrobial use. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 3, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic in Florida recognized as Center of Excellence for Antimicrobial Stewardship
JACKSONVILLE, Fla. — Mayo Clinic in Florida has been recognized as an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA) ― the only hospital in North Florida to hold that designation. This designation recognizes Mayo Clinic's optimal antimicrobial use and ongoing efforts to combat antimicrobial resistance. "We are honored to receive the IDSA Center of Excellence designation," says Julio Mendez, M.D., chair of Mayo C linic Florida's Antimicrobial Stewardship Program. "It is… (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - August 3, 2021 Category: Hospital Management Source Type: news

SMART breakthrough in detection of SARS-CoV-2 variant in wastewater
(Singapore-MIT Alliance for Research and Technology (SMART)) Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, alongside collaborators from Biobot Analytics, Nanyang Technological University (NTU) and Massachusetts Institute of Technology (MIT), have successfully developed an innovative, open-source molecular detection method that is able to detect and quantify the B.1.1.7 (Alpha) variant of SARS-CoV-2. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 21, 2021 Category: Biology Source Type: news

Antibiotic Resistance Crisis: An Update on Antagonistic Interactions between Probiotics and Methicillin-Resistant Staphylococcus aureus (MRSA)
Antimicrobial resistance (AMR) havoc is a global multifaceted crisis endowing a significant challenge for the successful eradication of devastating pathogens. Methicillin-Resistant Staphylococcus aureus (MRSA) is an enduring superbug involved in causing devastating infections. Although MRSA is a frequent colonizer of human skin, wound, and anterior nares, the intestinal colonization of MRSA has greatly increased the risk of inducing MRSA-associated colitis besides creating a conducive environment for horizontal transfer of resistant genes to commensal microbes. On the other hand, staphylococcal resistance to last-resort an...
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Are silver nanoparticles a silver bullet against microbes?
Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They can be in the form of antibiotics, used to treat bodily infections, or as an additive or coating on commercial products used to keep germs at bay. These life-saving tools are essential to preventing and treating infections in humans, animals and plants, but they also pose a global threat to public health when microorganisms develop resistance to them, a concept known as antimicrobial resistance. (Source: World Pharma News)
Source: World Pharma News - July 14, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Are silver nanoparticles a silver bullet against microbes?
(University of Pittsburgh) Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They are essential to preventing and treating infections, but they also pose a global threat to public health when microorganisms develop antimicrobial resistance. A University of Pittsburgh lab studied the mechanisms behind bacterial resistance to silver nanoparticles to determine if their ubiquitous use is a solution to this challenge or if it is perhaps fueling the fire. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats
NEW BRUNSWICK, N.J., July 9, 2021 – Johnson & Johnson (the Company) today announced the launch of the J&J Centers for Global Health Discovery (J&J Centers), a new, global network of unique research partnerships that will leverage the institutional strengths of Johnson & Johnson and leading academic institutions to accelerate discovery research to address the world’s most pressing global health challenges. The first J&J Satellite Center for Global Health Discovery (Satellite Center) was launched at the London School of Hygiene & Tropical Medicine (LSHTM) at an event co-hosted by Johnson &...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Antimicrobial Resistance Threat Continues During COVID Antimicrobial Resistance Threat Continues During COVID
The COVID-19 pandemic may have temporarily shifted the focus away from fighting antimicrobial resistance for some, but it did not dimmish the urgency.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 2, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘ One Health ’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security. (Source: University of Bristol news)
Source: University of Bristol news - June 17, 2021 Category: Universities & Medical Training Tags: Health, Research, International; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol Veterinary School, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Schoo Source Type: news

GW4 takes a One Health approach to tackling the antimicrobial resistance pandemic
(University of Bath) The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities -- GW4) formally launch their new 'One Health' antimicrobial resistance research consortium today. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 16, 2021 Category: Infectious Diseases Source Type: news

To Improve Global Health Security, We Must Not Abandon Tackling Existing Epidemics
Over 600 million people in Africa require treatment for an NTD, making up 35% of the global burden. Credit: Uniting to Combat NTDsBy Thoko Elphick-PooleyHOVE, United Kingdom, Jun 11 2021 (IPS) As world leaders come together in the UK for the G7, the global response to COVID-19 and how we can build a better defence system against infection is at the forefront of discussions.  Whilst we applaud the incredible global efforts in tackling COVID-19 and support calls for vaccines to be shared equitably across the world, we also urge G7 leaders not to abandon efforts to tackle existing epidemics such as neglected tropical dis...
Source: IPS Inter Press Service - Health - June 11, 2021 Category: International Medicine & Public Health Authors: Thoko Elphick Pooley Tags: Headlines Health TerraViva United Nations Neglected Tropical Diseases (NTDs) Source Type: news

What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
You don’t want to be a virus in Dr. David Ho’s lab. Pretty much every day since the COVID-19 pandemic began, Ho and his team have done nothing but find ways to stress SARS-CoV-2, the virus that causes the disease. His goal: pressure the virus relentlessly enough that it mutates to survive, so drug developers can understand how the virus might respond to new treatments. As a virologist with decades of experience learning about another obstinate virus, HIV, Ho knows just how to apply that mutation-generating stress, whether by starving the virus, bathing it in antibodies that disrupt its ability to infect cells, ...
Source: TIME: Health - June 11, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Genetics Magazine Source Type: news

International travel may spread destination-specific antimicrobial resistance genes
(BMC (BioMed Central)) Travelers abroad may pick up bacteria and other vectors containing genes conferring antimicrobial resistance which remain in the gut when returning to their home country, according to a study published in Genome Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

Global travelers pick up numerous genes that promote microbial resistance
(Washington University School of Medicine) Research from Washington University School of Medicine in St. Louis shows that international travelers often return home with new bacterial strains jostling for position among the thousands that normally reside within the gut microbiome. Such travel is contributing to the rapid global increase and spread of antimicrobial resistance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2021 Category: International Medicine & Public Health Source Type: news

Omani doctor on a mission to combat antimicrobial resistance
Imagine surviving a severe illness like cancer only to die from an infection caused by germs resistant to antimicrobial drugs. 28 May 2021 The helplessness of being called to the scene too late for patients who were previously on their way to recovery from illness or surgery, drove Dr Amal Saif Al-Maani and her colleagues to lead the race against antimicrobial resistance (AMR) upstream. Since 2015 and for more than 10 years now, they advocated for, developed and implemented a national strategy to control antimicrobial resistance. “As an infectious disease specialist, by the time you get involved, there is nothing...
Source: WHO EMRO News - May 30, 2021 Category: Middle East Health Source Type: news